Items where Author is "Matzdorff, A."

Article

Knoedler, M. and Gauler, T. C. and Gruenwald, V. and Matzdorff, A. and Schroeder, M. and Dietz, A. and Jordan, W. -O. and Arnold, D. and Hennemann, B. and Hofele, C. and Weissinger, F. and Eberhardt, W. and Keilholz, U. (2013) Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie. ONCOLOGY, 84 (5). pp. 284-289. ISSN 0030-2414

Hofheinz, R. and Wenz, F. K. and Post, S. and Matzdorff, A. and Laechelt, S. and Hartmann, J. T. and Mueller, L. and Link, H. and Moehler, M. H. and Kettner, E. and Fritz, E. and Hieber, U. and Lindemann, H. W. and Grunewald, M. and Kremers, S. and Constantin, C. and Hipp, M. and Gencer, D. and Burkholder, I. and Hochhaus, A. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo) adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 3504. ISSN 0732-183X, 1527-7755

Hofheinz, R-D and Wenz, F. and Post, S. and Matzdorff, A. and Laechelt, S. and Hartmann, J. T. and Mueller, L. and Link, H. and Moehler, M. and Kettner, E. and Fritz, E. and Hieber, U. and Lindemann, H. W. and Grunewald, M. and Kremers, S. and Constantin, C. and Hipp, M. and Gencer, D. and Burkholder, I and Hochhaus, A. (2011) Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo-)adjuvant chemo-radiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial. ONKOLOGIE, 34 (Suppl6). p. 199. ISSN 0378-584X

Knoedler, M. and Gauler, T. C. and Matzdorff, A. and Dietz, A. and Gruenwald, V. and Arnold, D. and Hennemann, B. and Schroeder, M. and Hofele, C. and Schmittel, A. and Keilholz, U. (2008) Phase II trial to evaluate efficacy and toxicity of cetuximab plus docetaxel in platinum pretreated patients with recurrent and/or metastatic head and neck cancer. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 6066. ISSN 0732-183X

Conference or Workshop Item

Knoedler, M. K. and Gauler, T. C. and Matzdorff, A. and Jordan, O. and Schroeder, M. and Gruenwald, V. and Dietz, A. and Hennemann, B. and Arnold, D. and Keilholz, U. (2008) CETUXIMAB PLUS DOCETAXEL AS TREATMENT FOR RECURRENT AND/OR METASTATIC HEAD AND NECK CANCER. In: 33rd European Society for Medical Oncology Congress, September 12-16, 2008, Stockholm, Sweden.